Improvement in Periodontitis Following Conservative Periodontal Treatment in a Type 1 Diabetic Patient

Authors

  • Edmund Julian Ofilada St. Luke's Medical Center
  • Cecilia Jimeno Associate Professor, UP College of Medicine Department of Pharmacology Clinical Associate Professor, UP PGH Section of Endocrinology Diabetes and Metabolism Pedro Gil Street, Malate, Manila, Philippines
  • Jerome Barrera Endocrinologist, Training Officer, Department of Internal Medicine, Zamboanga City Medical Center, Dr Evangelista St. Zamboanga City

Abstract

We report a case of severe gingival bleeding in a 15-year old, type 1 diabetic female.  Examination revealed severe gingival inflammation with periodontal pockets (<6 mm), indicating mild-moderate periodontitis. Periodontal therapy resulted in reduction of fructosamine level (-72.98) after four weeks, but HbA1c level checked 3 months after treatment increased (+0.7).  Reduction in gingival bleeding and periodontal pockets improved the patient’s quality of life.  Insulin resistance is offered as a possible reason for non-improvement in HbA1c levels.

Downloads

Download data is not yet available.

Author Biography

Edmund Julian Ofilada, St. Luke's Medical Center

Consultant, Dentistry and Oral Surgery Service St. Luke's Medical Center

References

Davidson MB, Schriger DL, Peters AL, Lorber B. Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus. JAMA. 2000;283(5):606-607.

Van Dyke TE. The management of inflammation in periodontal disease. J of Periodontol. 2008;79(8):1601-1608.http://dx.doi.org/ 10.1902/jop.2008.080173.

Löe H. Periodontal disease: The sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329-334. http://dx.doi.org 10.2337/diacare.16.1.329.

Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ. Treatment of periodontal disease for glycaemic control in people with diabetes. Aust Dent J.2010;55(4):472-474. http://dx.doi.org/10.1111/j.1834-7819.2010.01273.

Aldridge JP, Lester V, Watts TL, Collins A, Viberti G, Wilson RF. Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. J.Clin Periodontol.1995;22(4):271–5. http://dx.doi.org/10.1111/j.1600-051X.1995.tb00147.x.

Smith GT, Greenbaum CJ, Johnson BD, Persson GR. Short-term responses to periodontal therapy in insulin-dependent diabetic patients. J of Periodontol.1996;67(8): 794-802. http://dx.doi.org/10.1902/jop.1996.67.8.794.

Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J ClinPeriodontol.1996; 23(2): 92-100. http://dx.doi.org/10.1111/j.1600-051X.1996.tb00540.x.

Llambés F, Silvestre FJ, Hernández-Mijares A, Guiha R, Caffesse R. The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus. Clin Oral Investig.2008;12(4):337-43. http://dx.doi.org/10.1007/s00784-008-0201-0.

Craig ME, Hattersley A and Donaghue KC. Definition, epidemi¬ology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10(Suppl. 12):3–12. http://dx.doi.org/10.1111/j.1399-5488.2009.00568.x.

Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J. Clin Endocrinol Metab. 2006;91(2):401–404. http://dx.doi.org/10.1210/jc.2005-1672.

Miller J, Silverstein JH, Rosenbloom AL. Type 2 diabetes in the child and adolescent. In: LIFSHITZ F (ed) Pediatric Endocrinology: Fifth edition, volume 1. New York: Marcel Dekker 2007: pp 169–188.

Meisel P, Wilke P, Biffar R, Holtfreter B, Wallaschofski H, Kocher T. Total tooth loss and systemic correlates of inflammation: role of obesity. Obesity (Silver Spring).2012; 20(3): 644-650. http://dx.doi.org/10.1038/oby.2011.218.

D’Aiuto F, Orlandi M, Gunsolley JC. Evidence that periodontal treatment improves biomarkers and CVD outcomes. Jof Clin Periodontol. 2013;40(Suppl.14): S85-S105. http://dx.doi.org/10.1111/jcpe.12061.

Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med. 2003;163(10): 1172–1179. http://dx.doi.org/10.1001/archinte.163.10.1172.

Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44(1):127-153. http://dx.doi.org/10.1111/j.1600-0757.2006.00193.x.

Ofilada EJL. Managing periodontitis in type 1 diabetic patients improve glycemic control. St. Luke’s Journal of Medicine. In press.

Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J of Periodontol Online. 2005;76 (11-s):2075-2084. http://dx.doi.org/10.1902/jop.2005.76.11-S.2075.

Barrera JR, Jimeno CA, Paz-Pacheco E. Insulin resistance among adults with type 1 diabetes mellitus at the Philippine General Hospital. J Diabetes Metab. 2013;4:10. http://dx.doi.org/10.4172/2155-6156.1000315.

Downloads

Published

2015-07-31

How to Cite

Ofilada, E. J., Jimeno, C., & Barrera, J. (2015). Improvement in Periodontitis Following Conservative Periodontal Treatment in a Type 1 Diabetic Patient. Journal of the ASEAN Federation of Endocrine Societies, 30(1), 59. Retrieved from https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/206

Issue

Vol. 30 No. 1 (2015): May Issue

Section

Case Reports

License

The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.

To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.

A written agreement will be issued to the requester once permission has been granted.